Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Diet Therapy × Breast × Clear all

Phase

Phase NA 13 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Gastrointestinal 2 Dermatologic 1 Breast 1

Conditions

Stage IV Breast Cancer AJCC v6 and v7 1

Interventions

Paclitaxel 88 Trastuzumab 73 pembrolizumab 69 Cyclophosphamide 60 Fulvestrant 58 Capecitabine 43 Docetaxel 40 Carboplatin 40 Lapatinib 39 palbociclib 35 Letrozole 33 Doxorubicin 26 olaparib 25 Taxes 24 Gemcitabine 24 Nivolumab 23 Magnetic Resonance Spectroscopy 23 130-nm albumin-bound paclitaxel 22 Everolimus 21 Biopsy 21 Cisplatin 19 abemaciclib 18 Specimen Handling 18 Bevacizumab 18 Albumin-Bound Paclitaxel 18 ribociclib 17 Radiotherapy 17 Ado-Trastuzumab Emtansine 17 pertuzumab 16 exemestane 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03535701 2025-06-08

KETO-CARE

Ohio State University Comprehensive Cancer Center

Phase 1 Completed

Stage IV Breast Cancer AJCC v6 and v7

Data powered by HemOnc (CC BY 4.0) Colophon ⚡